Skip to main content
Clinical Trials/NCT04630249
NCT04630249
Completed
Not Applicable

Pilot RCT of Remote Mental Health and Substance Use Screening, Brief Intervention and Referral to Treatment (SBIRT), Compared to In-Person SBIRT for Peripartum Women

Medical University of South Carolina1 site in 1 country415 target enrollmentDecember 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy
Sponsor
Medical University of South Carolina
Enrollment
415
Locations
1
Primary Endpoint
Completion of SBIRT (Specific Aim 1)
Status
Completed
Last Updated
last year

Overview

Brief Summary

Specific Aim 1: Conduct a pilot, small-scale randomized controlled trial to examine feasibility and preliminary efficacy of LTW, compared to TAU. Outcomes related to feasibility include percentage of eligible patients recruited, study attrition, study retention, and mental health and substance use treatment appointment attendance. Outcomes related to preliminary efficacy will include participation in screening, referral and treatment at baseline, compared to TAU.

Specific Aim 2: Conduct a randomized controlled trial to examine the effectiveness of LTW, compared to TAU. Outcomes related to effectiveness include screening, screening positive, referred to and attendance to treatment at baseline, compared to TAU.

Detailed Description

Participants: 450 adult, pregnant or postpartum women Intervention: Listening to Women is a mobile phone-based program designed to enhance delivery of Screening, Brief Intervention, and Referral to Treatment (SBIRT), an evidence-based approach for mental health and substance use screening and treatment for perinatal women. This program was created as a result of key informant interviews with obstetric providers and pregnant and postpartum women with opioid use disorders. The program utilizes mobile phone text message-based screenings with immediate automated feedback, paired with remote care coordination and, if appropriate, home-based telemedicine mental health and substance use disorder treatment services. Design: Specific aim 1: A two arm pilot RCT (N=35) with 2:1 allocation will examine feasibility and preliminary efficacy of LTW, compared to TAU. Specific aim 2: A RCT (N=415) with 1:1 allocation will examine effectiveness of LTW, compared to TAU. This study is part of the HEAL Initiative (https://heal.nih.gov/).

Registry
clinicaltrials.gov
Start Date
December 15, 2020
End Date
July 21, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Constance Guille

Professor

Medical University of South Carolina

Eligibility Criteria

Inclusion Criteria

  • age 18-41; 2) currently pregnant or postpartum; 3) if pregnant, receiving prenatal care; 4) English fluency; 5) owner of a cell phone with short message service (SMS) text-message based capability; 6) access to Wireless Fidelity (WIFI) and a device to allow audio and video teleconferencing; 7) able to provide informed consent.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Completion of SBIRT (Specific Aim 1)

Time Frame: Baseline

We will compare the proportion of participants that complete a screen for mental health and substance use among those assigned to LTWP, compared to TAU.

Screened Positive (Specific Aim 1)

Time Frame: Baseline

We will compare the proportion of those screening positive that are referred to treatment among those assigned to LTWP, compared to TAU.

Referred to Treatment (Specific Aim 1)

Time Frame: Baseline

We will compare the proportion of participants referred to treatment that had at least one mental health and/or substance use disorder treatment appointment among those assigned to LTWP, compared to TAU.

Treatment Attendance (Specific Aim 1)

Time Frame: Baseline

Treatment attendance (defined as attending at least 1 or more visits with a mental health and/or substance use disorder (SUD) treatment provider during pregnancy and the postpartum year)

Secondary Outcomes

  • Screened Positive (Specific Aim 2)(Baseline)
  • Referred to Treatment (Specific Aim 2)(Baseline)
  • Treatment Attendance (Specific Aim 2)(Baseline)

Study Sites (1)

Loading locations...

Similar Trials